Union Bancaire Privee, Ubp Sa Ionis Pharmaceuticals Inc Transaction History
Union Bancaire Privee, Ubp Sa
- $4.34 Billion
- Q1 2025
A detailed history of Union Bancaire Privee, Ubp Sa transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Union Bancaire Privee, Ubp Sa holds 265 shares of IONS stock, worth $9,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265
Previous 265
-0.0%
Holding current value
$9,807
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
401Shares Held
146MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$606 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$599 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$458 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$382 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$311 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.25B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...